Delivery Order SPE2DX15D3003-SPE2DX24F5M2J
- Not listed
- This delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Lantus SoloStar 100 Unit/mL 3mL, a brand name insulin medication, at a ceiling value of $2,048.61. It is a firm fixed price contract type with a performance period through March 12, 2024. No set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,769.42, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a brand name insulin product, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- This is a delivery order under the Amerisourcebergen Drug Corp's (Amerisourcebergen) Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin product, to an unspecified location. The order has a ceiling value of $5,169.50 and is a firm fixed-price contract. Amerisourcebergen, a major pharmaceutical...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,316.90, is for the supply of Lantus SoloStar 100 unit/mL 3mL, a brand name insulin product. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, with a ceiling value of $1,002.84 and a completion date of May 13, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lantus SoloStar insulin (100 unit/mL, 3mL formulation) with a ceiling value of $1,022.80. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award to the vendor. The contract is to be completed by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,884.04 firm fixed-price contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, with a completion date of January 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,518.84 firm fixed price contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,969.00 order is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a brand name insulin medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Lantus Solostar 100 unit/ml 3ml, a brand-name insulin product. The contract has a ceiling value of $1,187.60 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the...
- SPE2DX15D3003Indefinite Delivery Contract
- SPE2DX15D3003-SPE2DX24F5M2JDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract has a firm fixed price pricing type and a ceiling value of $2,078.30. It is for the supply of Lantus SoloStar 100 unit/mL 3mL, a brand name insulin product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This specific delivery order is issued under that IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/18/24 |